Types of Blood Transfusion Reactions
Blood transfusion reactions can be broadly categorized into immune-mediated and non-immune-mediated reactions, with specific subtypes in each category that require different management approaches. 1
Immune-Mediated Reactions
Type I (IgE antibody-mediated)
- Allergic reactions ranging from mild urticaria to severe anaphylaxis 1
- Characterized by hives, generalized itching, flushing, and in severe cases, respiratory compromise and hypotension 1
- Accounts for approximately one-third of all transfusion reactions 2
Type II (Antibody-mediated cytotoxic)
- Hemolytic transfusion reactions (acute or delayed) 1
- Results from destruction of transfused red blood cells by recipient antibodies 1
- May present with fever, hypotension, flank pain, hemoglobinuria, and in severe cases, renal failure 3
- Preventable through proper antigen matching, particularly Rh (C, E or C/c, E/e) and K antigens 1
Type III (Immune complex-mediated)
- Includes serum sickness and vasculitis 1
- Characterized by fever, rash, arthralgia, and lymphadenopathy 1
- Typically occurs 1-2 weeks after transfusion 4
Type IV (Delayed T cell-mediated)
- Includes allergic contact dermatitis, maculopapular exanthema, erythema multiforme, and toxic epidermal necrolysis 1
- Typically presents days to weeks after transfusion 1
Non-Immune-Mediated Reactions
Febrile Non-Hemolytic Transfusion Reactions (FNHTR)
- Second most common reaction (25.7% of reactions) 2
- Characterized by fever (≥1°C rise) and chills without hemolysis 5
- Usually self-limiting but can mask more serious reactions 6
Transfusion-Related Acute Lung Injury (TRALI)
- Acute respiratory distress within 6 hours of transfusion 5
- Presents with hypoxemia, bilateral pulmonary infiltrates without evidence of circulatory overload 5
- Among the top three most common causes of transfusion-related deaths 5
- Most patients recover within 96 hours with supportive care 5
Transfusion-Associated Circulatory Overload (TACO)
- Volume overload leading to pulmonary edema 3, 5
- Risk factors include elderly patients, cardiac dysfunction, and rapid transfusion rates 5
- Presents with dyspnea, orthopnea, hypertension, and jugular venous distention 3
Septic Transfusion Reactions
- Due to bacterial contamination of blood products 5
- Presents with fever, hypotension, and shock 4
- Requires immediate antibiotic therapy and supportive care 5
Cytokine Release Syndrome (CRS)
- Pseudo-allergic reaction with direct mast cell degranulation 1
- Presents with tachycardia, hypotension, rash, and shortness of breath 1
Special Considerations in Sickle Cell Disease
- Patients with sickle cell disease are at higher risk for alloimmunization and delayed hemolytic transfusion reactions 1
- Prophylactic red cell antigen matching for Rh (C, E or C/c, E/e) and K antigens is strongly recommended over only ABO/RhD matching 1
- In rare cases of life-threatening anemia requiring immediate transfusion when compatible blood is unavailable, immunosuppressive therapy (IVIg, steroids, and/or rituximab) may be considered 1
Immediate Management of Suspected Transfusion Reactions
- Stop the transfusion immediately when any signs or symptoms of a reaction appear 3, 5
- Maintain IV access with normal saline 3
- Check patient identification and blood component compatibility labels 3
- Notify the transfusion laboratory immediately 3
- Assess ABCs (Airway, Breathing, Circulation) and level of consciousness 3
- Position the patient appropriately based on symptoms 3
- Monitor vital signs closely 5
- Collect post-reaction blood samples for laboratory evaluation 3
Common Pitfalls and Caveats
- General anesthesia may mask symptoms of both hemolytic and nonhemolytic transfusion reactions 5
- Diagnosis of a transfusion reaction during ongoing hemorrhage may be difficult 5
- Symptoms of different reaction types often overlap and can be nonspecific 7
- The reporting rate of transfusion reactions varies significantly between institutions and countries 4, 8
- Any symptom occurring within 24 hours of a blood transfusion should be considered a potential transfusion reaction 4